In the aspect of NAFLD severity, the probiotics decreased the percentage of moderate and severe FL but had no effect on reducing the levels of ALT, AST, TG and insulin resistance (76–83). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.